Skip to main content
HeartCited

Chitosan für High Triglycerides (Hypertriglyceridemia)

D Forschung Es existiert nur vorläufige Forschung (Laborstudien, Fallberichte).

Limited evidence for modest triglyceride reduction. Fat-binding mechanism may reduce dietary triglyceride absorption. Results are inconsistent across studies.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dchitosan\u0026condition\u003Dtriglycerides'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

Fazit

Limited evidence for modest triglyceride reduction. Fat-binding mechanism may reduce dietary triglyceride absorption. Results are inconsistent across studies.

Key Study Findings

Other
Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical …
Dose: None vs.: None Outcome: Cognitive function Wirkung: None None

Population: Rat model

Other
Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity.
Dose: None vs.: None Outcome: Oxidative stress, neuroinflammation, apoptosis Wirkung: None None

Population: AlCl3-induced neurotoxicity rat model

Key Statistics

3

Studien

200

Teilnehmer

Positive

D

Bewertung

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

fatbinding:
1,500-3,000 mg/day before meals
cholesterolsupport:
1,000-3,000 mg/day

Obergrenze: Not formally established; GI side effects at higher doses

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Positive --
None -- Positive --

Beste Einnahmezeit: 15-30 minutes before meals containing dietary fat

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Constipation
  • Gas and bloating
  • Nausea
  • Allergic reactions in those with shellfish allergy (contraindicated)

Bekannte Wechselwirkungen

  • Fat-soluble vitamins (A, D, E, K — may reduce absorption)
  • Oral medications (may bind and reduce absorption — separate by 2 hours)
  • Warfarin (may reduce vitamin K absorption, affecting INR)

Tolerierbare Höchstaufnahmemenge: Not formally established; GI side effects at higher doses

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Chitosan help with High Triglycerides (Hypertriglyceridemia)?
Based on 3 studies with 200 participants, there is preliminary evidence that needs more research that Chitosan may support High Triglycerides (Hypertriglyceridemia) management. Our evidence grade is D (Very Early Research).
How much Chitosan should I take for High Triglycerides (Hypertriglyceridemia)?
Studies have used various dosages. A commonly studied range is 1,500-3,000 mg/day before meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Chitosan?
Reported side effects may include Constipation, Gas and bloating, Nausea, Allergic reactions in those with shellfish allergy (contraindicated). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Chitosan and High Triglycerides (Hypertriglyceridemia)?
We rate the evidence as Grade D (Very Early Research). This rating is based on 3 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

Andere Inhaltsstoffe für High Triglycerides (Hypertriglyceridemia)

Chitosan für andere Beschwerden

References

  1. [1] Eman N Hosny et al.. Physiol Behav. 2024. Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical changes in high-fat diet-induced obese … doi:10.1016/j.physbeh.2024.114697 PubMed
  2. [2] Heba H Metwaly et al.. Toxicol Mech Methods. 2022. Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity. doi:10.1080/15376516.2021.1998275 PubMed
  3. [3] Norhayati Mohamed Noor et al.. Pharmaceutics. 2020. In Vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery. doi:10.3390/pharmaceutics12100994 PubMed

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.